(Q36883231)

16 August 2017

1 reference

title

Cardiovascular outcomes of CPAP therapy in obstructive sleep apnea syndrome (English)

1 reference

16 August 2017

1 reference

obstructive sleep apnea

1 reference

Walter T McNicholas

1

1 reference

16 August 2017

publication date

18 July 2007

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

16 August 2017

published in

1 reference

16 August 2017

volume

293

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

R1666-70

1 reference

Association of sleep-disordered breathing and the occurrence of stroke

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Continuous positive airway pressure treatment improves baroreflex control of heart rate during sleep in severe obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Early investigation and treatment of obstructive sleep apnoea after acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Pathophysiology of obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effect of continuous positive airway pressure on blood pressure : a placebo trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Phenotypic and Functional Characterization of Blood γδ T Cells in Sleep Apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep apnoea and nocturnal angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Reduction in motor vehicle collisions following treatment of sleep apnoea with nasal CPAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep. 5: Driving and automobile crashes in patients with obstructive sleep apnoea/hypopnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Continuous positive airways pressure for obstructive sleep apnoea in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Atherosclerosis. the road ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep.7: positive airway pressure therapy for obstructive sleep apnoea/hypopnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep-disordered breathing after stroke: a randomised controlled trial of continuous positive airway pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Endothelial Function in Obstructive Sleep Apnea and Response to Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Public health and medicolegal implications of sleep apnoea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Oral appliances for obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

High prevalence of unrecognized sleep apnoea in drug-resistant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Silent brain infarction and platelet activation in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Amelioration of vascular endothelial dysfunction in obstructive sleep apnea syndrome by nasal continuous positive airway pressure--possible involvement of nitric oxide and asymmetric NG, NG-dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Respiratory disturbance index: an independent predictor of mortality in coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Prospective study of the association between sleep-disordered breathing and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Association of sleep apnea and type II diabetes: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep x 9: an approach to treatment of obstructive sleep apnoea/hypopnoea syndrome including upper airway surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Influence of treatment on leptin levels in patients with obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Adherence to positive airway pressure therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Obstructive sleep apnea as a risk factor for stroke and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

Effect of continuous positive airway pressure and placebo treatment on sympathetic nervous activity in patients with obstructive sleep apnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00401.2007

10.1152/AJPREGU.00401.2007

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference